Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017)
Organogenesis Holdings (ORGO) posted Income from Non-Controlling Interests of $273000.0 for Q2 2017, down 53.73% on a QoQ basis from $590000.0 in Q1 2017.
Powered by 
Analysis
Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017) Analysis & Trends
Organogenesis Holdings has reported Income from Non-Controlling Interests for 1 years, with the latest figure at $273000.0 in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | 900,000.00 |
| 10 | Organogenesis Holdings | 200.85 Mn | 154.00 Mn | 20.08 Mn | - |